Nevro Corp., a California-based medical device company, has gained international recognition for its innovative products aimed at treating chronic pain. With a focus on evidence-based neuromodulation solutions, Nevro Corp. has developed a range of products including the Senza spinal cord stimulation (SCS) system, Senza II and Senza Omnia SCS systems, and 10 kHz Therapy. These products have been instrumental in providing relief to patients suffering from chronic pain across the United States and beyond. One of the company's flagship products is the Senza HFX iQ IPG system, which includes a range of features such as the implantable pulse generator, trial stimulator, and patient remote. Additionally, the system boasts a patient remote control, wireless trialing system, and a specialized App for managing and controlling the device. Nevro Corp. also provides surgical and percutaneous leads. Nevro Corp.'s products are distributed through various channels, including a direct sales force, sales agents, and independent distributors. Founded in 2006, the company has become a leader in the medical device industry, providing cutting-edge solutions to help patients suffering from chronic pain.
Nevro's ticker is NVRO
The company's shares trade on the NYSE stock exchange
They are based in Redwood City, California
There are 201-500 employees working at Nevro
It is nevro.com/English/us/home/default.aspx
Nevro is in the Healthcare sector
Nevro is in the Medical Appliances & Equipment industry
The following five companies are Nevro's industry peers: